Personalized treatment shows promise for rare salivary gland cancer
NCT ID NCT05924256
First seen Jan 04, 2026 · Last updated May 21, 2026 · Updated 20 times
Summary
This study tests targeted drugs for advanced salivary gland cancer that has spread or come back. Researchers group patients by genetic markers (like HER-2 or AR) to match them with a specific therapy. The goal is to see if this personalized approach shrinks tumors or slows the disease. 88 adults aged 18-75 are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SALIVARY GLAND CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dongmei Ji
Shanghai, China
Conditions
Explore the condition pages connected to this study.